Clinical trial
A Pivotal, Prospective, Multi-centre, Randomised Controlled, 6-month Blinded Investigation Followed by a 6-month Open-label Phase Evaluating the Efficacy of a Dexamethasone Eluting Slim Straight Electrode (CI622D) in the Reduction of Impedance as Compared to a Standard Slim Straight Electrode (CI622) in a Newly Implanted Adult Population With Post-linguistic, Bilateral, Moderately Severe to Profound Sensorineural Hearing Loss.
NCT06424262 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal, Prospective, Multi-centre, Randomised Controlled, 6-month Blinded Investigation Followed by a 6-month Open-label Phase Evaluating the Efficacy of a Dexamethasone Eluting Slim Straight Electrode (CI622D) in the Reduction of Impedance as Compared to a Standard Slim Straight Electrode (CI622) in a Newly Implanted Adult Population With Post-linguistic, Bilateral, Moderately Severe to Profound Sensorineural Hearing Loss.
- Lead sponsor
- Cochlear
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 17, 2024
- Completion date
- May 6, 2026
- Enrollment
- 50 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
hearing loss, bilateral, hearing loss, bilateral sensorineural, hearing loss, cochlear, hearing loss, sensorineural